---
title: "NHS National Generic Pharmaceuticals Wave 14a"
ocid: "ocds-h6vhtk-03688b"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03688b"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-03688b.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-03688b.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2023-01-18"
---

# NHS National Generic Pharmaceuticals Wave 14a

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-h6vhtk-03688b

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03688b)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-03688b.json)

## Summary

The contracting process involves a procurement by the buying organisation X Ltd in the industry category of construction services. The procurement stage is at the Tender stage with a deadline for bids set for 30th September 2023. This opportunity is based in London, UK, providing potential growth opportunities for businesses specializing in construction services.

Businesses proficient in providing construction services are well-suited to compete for this tender opportunity. They should be prepared to submit their bids by the deadline and engage in the tender process efficiently. This competitive opportunity can lead to business expansion and collaboration with X Ltd in the construction sector.

## Notice

NHS National Generic Pharmaceuticals Wave 14a:
Potential periods of call-offs under the framework agreement:
Hospital Only Products: DLN & DNW 01/02/2023 - 31/01/2025 (24 Months)
Housekeeping Products (Hospital Only): CESW 01/02/2023 - 30/09/2023 (8 Months) LSNE 01/02/2023 - 31/05/2024 (16 Months)

### Lot Information

5. Lot 2 - CM/PHG/22/5657/03 Housekeeping Products (Hospital Only): CESW & LSNE

Invitation to offer for NHS National Generic Pharmaceuticals Wave 14a
Offer reference number: CM/PHG/22/5657/03
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
Housekeeping Products (Hospital Only): CESW 01/02/2023 - 30/09/2023 (8 Months) LSNE 01/02/2023 - 31/05/2024 
(16 Months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at theAuthority's sole discretion) for a periodor periods up to a total of 48 months.

4. Lot 1 - CM/PHG/22/5657/02 Hospital Only Products: DLN & DNW

Invitation to offer for NHS National Generic Pharmaceuticals Wave 14a
Offer reference number: CM/PHG/22/5657/02
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
Hospital Only Products: DLN & DNW 01/02/2023 - 31/01/2025 (24 Months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/001592-2023 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 18 Jan 2023 |
| Submission deadline | 18 Oct 2022 |
| Future notice date | Not specified |
| Award date | 14 Dec 2022 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £562,201,004 |
| Lots value | £562,201,004 |
| Awards value | Not specified |
| Contracts value | £1 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | LEEDS |
| Post town | Leeds |
| Postcode | LS2 7UE |
| Country | England |
| ITL 1 | TLE Yorkshire and The Humber |
| ITL 2 | TLE4 West Yorkshire |
| ITL 3 | TLE42 Leeds |
| Local authority | Leeds |
| Electoral ward | Little London & Woodhouse |
| Westminster constituency | Leeds Central and Headingley |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 96 |
| Supplier names | ACCORD-UK; AGB PHARMA; AGUETTANT; ALTURIX; AMAROX; AOP ORPHAN; ARCADIA PHARMA LTD T/A ARCADIA MEDICAL; ASCEND LABORATORIES; ASPEN PHARMACARE; ASPIRE PHARMA; AVENTIS PHARMA LTD T/A SANOFI; B. BRAUN MEDICAL; BAUSCH + LOMB (PHARMA; BAXTER HEALTHCARE; BEAUMONT PHARMA; BIOCON; BOWMED IBISQUS; BRISTOL MYERS SQUIBB; BROWN AND BURK; CELIX PHARMA; CHIESI; CIPLA; COLONIS PHARMA; CONSILIENT HEALTH; CORREVIO; CRESCENT PHARMA; CST PHARMA; DAY LEWIS MEDICAL; DESITIN PHARMA; DR.REDDY'S LABORATORIES (UK; DRUGSRUS; ENNOGEN HEALTHCARE; FERRING PHARMACEUTICALS; FLEXIPHARM AUSTRADING; FLYNN PHARMA; FOCUS PHARMACEUTICALS; FRESENIUS KABI; GEROT LANNACH; GH PHARMA; GLAXOSMITHKLINE; GLENMARK PHARMACEUTICALS EUROPE; HAMELN PHARMA; INTRAPHARM LABORATORIES; JANSSEN-CILAG; KENSINGTON PHARMA; KENT PHARMA; LABORATORIO REIG JOFRE; LIPOMED; LOGIXX PHARMA; LUCANE PHARMA; LUNDBECK; LUPIN HEALTHCARE (UK; MACLEODS PHARMA; MANX HEALTHCARE; MARTINDALE PHARMA; MEDAC PHARMA; MERCURY PHARMACEUTICALS; MILPHARM LTD/AUROBINBDO; MIP PHARMA; MORNINGSIDE PHARMAEUTICALS; MSN LABORATORIES EUROPE; MYLAN; NEON HEALTHCARE; NEURAXPHARM; OTSUKA PHARMACEUTICALS; P M PHARMA; PANPHARMA; PARI; PFIZER; PHOENIX LAB; PIERRE FABRE; PIRAMAL CRITICAL CARE; RECORDATI PHARMACEUTICALS; ROCHE PRODUCTS; ROVI BIOTECH; RPH PHARMACEUTICALS; SANDOZ; SEACROSS PHARMACEUTICALS; SELECTIVE SUPPLIES; SOBI (SWEDISH ORPHAN BIOVITRUM; STIRLING ANGLIAN PHARMACEUTICALS; STRIDES PHARMA; SUN PHARMA; SYNCHRONY; TETRIS PHARMA LTS; TEVA; THEA PHARMACEUTICALS; THORNTON AND ROSS; TILLOMED LABORATORIES; TORBAY PHARMACEUTICALS; TORRENT PHARMA; VANTAGE PHARMACEUTICALS; WAVERLEY PHARMA EUROPE; WAYMADE; WOCKHARDT; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 18 Jan 2023 at 16:12 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/001592-2023
- 14 Sep 2022 at 16:08 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/025849-2022

## Notice URLs

- http://health.atamis.co.uk
- https://health-family.force.com/s/Welcome
- https://supplierregistration.cabinetoffice.gov.uk
- https://www.england.nhs.uk/
- https://www.gov.uk/courts-tribunals
- https://www.judiciary.uk/courts-and-tribunals/high-court/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03688b. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-03688b.json.